APMD

Apnimed, Inc. Common Stock

15.10

USD

+0.94

+6.64%

Nov 06, 15:59 UTC -5

Closed

After-Market

15.10

0.00

-0.03%

Apnimed, Inc. Common Stock (APMD) Profile

Apnimed, Inc. Common Stock Profile

About

Apnimed Inc. is a late stage clinical pharmaceutical company dedicated to the discovery, development and commercialization of novel oral therapies which address the neurobiology of sleep-related breathing diseases. Apnimed Inc. is based in CAMBRIDGE, Mass.

Info & Links

CEO

Kevin R. Lind

Headquarters

39 JOHN F. KENNEDY STREET, 4TH FLR.
CAMBRIDGE, MA 02138, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

Employees

Apnimed, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

628.42M

Enterprise Value

535.48M

Enterprise Value/EBITDA(ttm)

9.50

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

46.86%

Operating Margin(ttm)

Profit Margin(ttm)

280.59%

Return on Equity(ttm)

Return on Invested Capital(ttm)

-157.07%

Return on Assets(ttm)

Income Statement

Revenue(ttm)

96.89M

Revenue Per Share(ttm)

2.33

Gross Profit(ttm)

93.52M

EBITDA(ttm)³

56.35M

Net Income Available to Common(ttm)

193.65M

Diluted EPS(ttm)

Share Statistics

Beta (5Y Monthly)

52-Week Change

S&P 500 52-Week Change

14.03%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

41.63M

Dividend Yield

0.00%

Float⁴

0.00

% Held by Insiders

% Held by Institutions

Balance Sheet

Total Cash(mrq)

172.80M

Total Cash Per Share(mrq)

4.15

Total Debt(mrq)

79.86M

Total Debt/Equity(mrq)

-45.33%

Current Ratio(mrq)

5.19%

Quick Ratio(mrq)

5.19%

Book Value Per Share(mrq)

-36.69

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.17

Free Cash Flow(ytd)

-37.92M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.